The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Honeywell UOP's Rende Awarded Prestigious Society Of Chemical Industry Gordon E. Moore Medal

Thursday, June 28, 2012

Honeywell UOP's Rende Awarded Prestigious Society Of Chemical Industry Gordon E. Moore Medal09:00 EDT Thursday, June 28, 2012Medal recognizes Rende's outstanding track record of discovery, development, and commercialization of novel catalysts and adsorbentsDES PLAINES, Ill., June 28, 2012 /PRNewswire/ -- UOP LLC, a Honeywell (NYSE: HON) company, announced today that Dr. Dean Rende has been selected to receive the 2012 Society of Chemical Industry (SCI) Gordon E. Moore Medal for his outstanding record of discovery, scale-up, and commercialization of novel new catalysts used in the production of biodegradable detergents and petrochemical monomers.The SCI Gordon E. Moore Medal recognizes early-career success in innovation, as reflected both in market impact and improvement to quality of life. "Dean is an outstanding chemist and leader in UOP's Research and Development group. He is an inspiring leader in our search for efficient, effective energy solutions," said Dr. Rajeev Gautam, President and CEO, Honeywell UOP. "This medal from SCI is a tremendous recognition of Rende's accomplishments and a testament to all of the game-changing work being done at Honeywell's UOP to advance the fields ranging from refining and petrochemical to biofuels."By highlighting extraordinary individuals and their work, SCI aims to promote public understanding of research and development in modern chemical industries, enhance the interest of students in applied chemistry by providing role models, and emphasize the role of creative research in the global economy.SCI noted that Rende's discoveries have broad applicability in catalysis and have led to commercialization of a novel catalyst-manufacturing methodology currently used to produce catalysts in multiple technologies. Specifically, Rende has commercialized two novel industrial catalysts for commercial oxidation and alkane dehydrogenation, where more than 3 million tons are produced annually.In addition to his innovations in catalysis, Rende led the effort to developing an adsorbent ion exchange material that can selectively remove radioactive particle from water. The material, UOP IONSIV? Ion Exchangers, has been used at the Fukushima Daiichi nuclear power plant for removing radioactive cesium in the contaminated wastewater caused by the earthquake and tsunami in Japan in 2011.Rende is currently a senior manager for Adsorbents Research and Development at Honeywell's UOP, where he leads a group of about 20 scientists and engineers. Adsorbents are critical to the success of many processes in the energy industry, where they are used to remove contaminants in crude oil and natural gas streams. Rende's team is involved with increasing selectivity and capacity for some of UOP's existing adsorbents and also with developing adsorbents for new applications. In this role, he also works closely with UOP's manufacturing group to identify key procedures.  Rende is the author of nine peer-reviewed scientific articles and holds 14 U.S. patents. He has an additional 13 U.S. patent applications pending. Prior to joining Honeywell's UOP, Dr. Rende did post doctoral research at the University of Utah. Rende earned a bachelor's degree in chemistry from Franklin and Marshall College and a Ph.D. in chemistry from The Ohio State University.The Society of Chemical Industry (SCI) is a unique international forum where science meets business on independent, impartial ground. Anyone can join, and the Society offers a chance to share information between sectors as diverse as food and agriculture, pharmaceuticals, biotechnology, environmental science and safety. Originally established in 1881, SCI is a registered charity with individual Members in more than 70 countries. Its international headquarters are in London, UK, and it has offices in the U.S., Canada, Australia, India and mainland Europe. Ever since its foundation, SCI's principal objective has been to further the application of chemistry and related sciences for the public benefit. www.soci.org.UOP LLC, headquartered in Des Plaines, Illinois, USA, is a leading international supplier and licensor of process technology, catalysts, adsorbents, process plants, and consulting services to the petroleum refining, petrochemical, and gas processing industries. UOP is a wholly-owned subsidiary of Honeywell International, Inc. and is part of Honeywell's Performance Materials and Technologies strategic business group. For more information, go to www.uop.com. Honeywell (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; turbochargers; and performance materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit www.honeywellnow.com.This release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management's assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near- and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission. SOURCE HoneywellFor further information: Krystal Hughes, +1-847-391-3561, krystal.hughes@honeywell.com